Die Pentixapharm AG ist ein 2019 gegründetes biopharmazeutisches Unternehmen, das sich auf die Entwicklung von Radiopharmazeutika fokussiert. Das IPO erfolgte im Oktober 2024.
COMPANY
INVESTOR TERMSHEET
LEI:
3912005VBOVXNDXEQZ36
SECTOR:
Gesundheit
SUB-SECTOR:
Pharma
NAME
Pentixapharm Holding
WKN
A40AEG
ISIN
DE000A40AEG0
TICKER
PTP
INDEX
EXCHANGE
Xetra
The basic chart view shows the price movement of Pentixapharm Holding. If you are interested in additional analysis switch to the advanced chart view.
Visualisation of financial information has been one of boersengefluester.de's (BGFL) favourite disciplines from the very beginning. For this reason, we also put a lot of effort into maintaining our own database and have developed numerous analysis tools and key figure tables on this basis.
Even hardened fundamentalists probably look at the chart of a share before they start analysing it in any other way. Accordingly, boersengefluester.de (BGFL) has also developed a wide range of apps relating to chart technology and sophisticated scorings with technical chart components.
Advertising is an important revenue channel for us. But we understand, that sometimes it becomes annoying. If you want to reduce the number of shown ADs just simply login to your useraccount and manage the settings from there. As registered user you get even more benefits.
boersengefluester.de · #BGFL
· © 2024
The news manufactory
Good luck with all your investments
Founded in 2013 by Gereon Kruse, the financial portal boersengefluester.de is all about German shares - with a clear focus on second-line stocks. In addition to traditional editorial articles, the site stands out in particular thanks to a large number of self-developed analysis tools. All tools are based on a completely self-maintained database for more than 650 shares. As a result, boersengefluester.de produces Germany's largest profit and dividend forecast.
Contact
Idea & concept: 3R Technologies 
boersengefluester.de GmbH
Copyright © 2024
by Gereon Kruse
#BGFL